| Compound Information | SONAR Target prediction | | Name: | PUTRESCINE DIHYDROCHLORIDE | | Unique Identifier: | SPE01503952 | | MolClass: | Checkout models in ver1.5 and ver1.0 | | Molecular Formula: | C4Cl2H14N2 | | Molecular Weight: | 146.962 g/mol | | X log p: | -1.132 (online calculus) | | Lipinksi Failures | 0 | | TPSA | 0 | | Hydrogen Bond Donor Count: | 0 | | Hydrogen Bond Acceptors Count: | 2 | | Rotatable Bond Count: | 3 | | Canonical Smiles: | Cl.Cl.NCCCCN | | Source: | ex catabolism of ornithine | | Therapeutics: | ornithine decarboxylase inhibitor, cell growth factor | | Generic_name: | PUTRESCINE | | Chemical_iupac_name: | 1,4-DIAMINOBUTANE | | Drug_type: | Experimental | | Kegg_compound_id: | C00134 | | Drugbank_id: | EXPT02702 | | Logp: | -0.584 | | Cas_registry_number: | 110-60-1 | | Drug_category: | S-Adenosylmethionine Decarboxylase Proenzyme inhibitor | | Organisms_affected: | -1 |
| Species: |
4932 |
| Condition: |
APC9 |
| Replicates: |
2 |
| Raw OD Value: r im |
0.7045±0.00629325 |
| Normalized OD Score: sc h |
1.0039±0.0121208 |
| Z-Score: |
0.2180±0.661761 |
| p-Value: |
0.647696 |
| Z-Factor: |
-21.2802 |
| Fitness Defect: |
0.4343 |
| Bioactivity Statement: |
Nonactive |
| Experimental Conditions | | | Library: | Spectrum | | Plate Number and Position: | 13|B4 | | Drug Concentration: | 50.00 nM | | OD Absorbance: | 600 nm | | Robot Temperature: | 23.20 Celcius | | Date: | 2007-11-22 YYYY-MM-DD | | Plate CH Control (+): | 0.041475±0.00153 | | Plate DMSO Control (-): | 0.68835±0.02131 | | Plate Z-Factor: | 0.9201 |
|  png
ps
pdf |
| 450551 |
butane-1,4-diamine |
| 517672 |
4-azaniumylbutylazanium dichloride |
| 3452892 |
4-azaniumylbutylazanium |
| 5351466 |
butane-1,4-diamine hydrochloride |
| 6398426 |
azane; butane-1,4-diamine; platinum(+4) cation |
| internal high similarity DBLink | Rows returned: 1 | |
| active | Cluster 4140 | Additional Members: 3 | Rows returned: 0 | |
|
